Agile Therapeutics reported 1.53M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Adma Biologics ADMA:US $ 25.44M 2.57M
Agile Therapeutics AGRX:US 1.53M 4.17M
Bayer BAYN:GR € 5176M 1491M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
JAZZ PHA JAZZ:US $ 115.28M 20.87M
Johnson & Johnson JNJ:US $ 7598M 357M
Merk MRK:US $ 5334M 1507M
Pacira Pharmaceuticals PCRX:US $ 36.07M 2.93M
Pfizer PFE:US $ 10010M 399M
Teva Pharmaceutical Industries TEVA:US $ 1859M 116M
Therapeuticsmd TXMD:US 4.86M 123K